MedPath

Snack Foods and Their Impact on Gastrointestinal Microbiology, Function and Symptoms

Not Applicable
Completed
Conditions
Human Microbiome
Eating Behavior
Interventions
Dietary Supplement: Control snack
Dietary Supplement: Intervention snack 1
Dietary Supplement: Intervention snack 2
Registration Number
NCT03581812
Lead Sponsor
King's College London
Brief Summary

The purpose of this study is to evaluate the impact of replacing usual snacks with alternative snack foods on gut health in a population of habitual snackers with low fibre intake.

Detailed Description

Diet is a crucial target for the improvement of human health. In the modern world, diets are diverse and diet related diseases are becoming more and more common. In particular, it is becoming increasingly apparent that the bacteria that live in the gut are strongly linked to both diet and health. Bacteria in the gut can be beneficial or harmful, and the health of the gut relies on the beneficial bacteria outnumbering the harmful ones. Diet has a great impact on the bacterial composition of the gut. In turn, the gut bacteria play diverse roles in human health, influencing not only the gut but also the health of the immune system, heart and brain. Therefore, optimising the composition of the gut bacterial is vital to human health and wellbeing.

It has been shown that snacks between meals contributes 420 - 480 calories per day, almost a quarter of the recommended intake. Therefore, snack choices are an area of diet and lifestyle that have the potential to influence diet and in turn the health of our gut and gut bacteria. We would like to assess the effect of replacing usual snacks with alternative snack foods that we believe have benefits for gut health.

The primary aim of the study is to investigate whether the replacement of usual snacks has an effect on gut bacterial composition, specifically the abundance of Bifidobacteria. Secondary aims include the effect of the intervention snacks on additional measures of gut health such as gut transit time, the frequency and consistency of bowel movements and gut symptoms e.g. heartburn, nausea, belching etc. The effect of snack foods on metabolites in the blood (e.g. glucose, insulin, lipids) will also be determined. Finally the impact of snack replacement on mood and quality of life will be assessed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
87
Inclusion Criteria
  • Male or female
  • Aged between 18-45 years
  • Body mass index (BMI) of 18.5 - 29.9 kg/m2
  • Regular consumption of snacks (≥2 per day, excluding fruit and nut snacks)
  • Low fibre intake (<22 g/d)
  • Willing to follow the protocol and provide consent
Exclusion Criteria
  • Allergy or intolerance to snack ingredients (assessed at screening)
  • Dislike of study snacks
  • Regular consumption of intervention foods as snacks (twice a day in last month)
  • Diabetes
  • Major active psychiatric conditions (e.g. schizophrenia) or current eating disorder
  • Active treatment for cancer in the last year
  • Severe renal, cardiac or pulmonary disease or any other chronic medical condition
  • Severe oesophagitis, gastritis or duodenitis
  • Active diverticulitis or intestinal/colonic strictures
  • Crohns disease or Ulcerative colitis
  • Abdominal surgery (except appendicectomy or cholecystectomy)
  • Irritable bowel syndrome
  • Functional constipation
  • Functional diarrhoea
  • Antibiotics (past 4 weeks)
  • Ongoing therapy with drugs affecting gastrointestinal motility
  • Use of medical devices (Pacemakers, infusion pumps, insulin pumps)
  • Women who are pregnant/lactating/planning pregnancy
  • Recent/ongoing consumption of probiotics/prebiotics (past 4 weeks)
  • Ongoing abuse of alcohol/drugs/other medication
  • Very high physical activity levels
  • Unexplained/unintentional weight loss in the past 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control snackControl snackControl snack food reflecting the macro-nutrient profile of a typical UK snack.
Intervention snack 1Intervention snack 1Snack food believed to selectively promote the growth of beneficial bacterial strains in the human colon.
Intervention snack 2Intervention snack 2Snack food believed to selectively promote the growth of beneficial bacterial strains in the human colon.
Primary Outcome Measures
NameTimeMethod
Faecal bifidobacteriaDay 28

Measured by 16S community profiling (Illumina Miseq) of bacterial genomic DNA isolated from participant stool samples

Secondary Outcome Measures
NameTimeMethod
Regional gut transit timeDay 28

Measured using the SmartPill wireless motility capsule

Regional gut pHDay 28

Measured using the SmartPill wireless motility capsule

MoodDay 28

Hospital anxiety and depression scale

Faecal gut microbiota (alpha- and beta-diversity)Day 28

Measured by 16S community profiling (Illumina Miseq) of bacterial genomic DNA isolated from participant stool samples

Faecal short-chain fatty acids (SCFA)Day 28

Measured by gas liquid chromatography of stool sample

Dietary intakeWeek 4

7-day food diary

Dietary metabolites (various)Day 28

Measured in blood sample

Faecal volatile organic compoundsDay 28

Measured by gas-chromatography mass-spectrometry of stool samples

Gut symptomsweek 4

Gastrointestinal symptoms rating scale (7-day; questionnaire)

Quality of lifeDay 28

SF-36 questionnaire

Particle size of masticated snack foodsDay 28

Mechanical sieving and laser diffraction of masticated snack foods

Stool frequencyWeek 4

Bristol stool form scale(7-day; questionnaire)

Whole gut transit timeDay 28

Measured using the SmartPill wireless motility capsule

Faecal waterDay 28

Measured by lyophilization of stool sample

Physical activityDay 28

Recent physical activity questionnaire

Trial Locations

Locations (1)

King's College London Waterloo Campus

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath